Furthermore, later studies suggest that fractionated radiotherapy—as opposed to single-dose radiotherapy—induces systemic antitumor effects in combination with anti-CTLA-4 treatment in murine breast cancer models (160). Here, CTLA4 is linked to breast cancer.